Brief: Stayble Therapeutics Raises About SEK 31.7 Mln Through Rights Issue
April 14 (Reuters) - STAYBLE THERAPEUTICS AB STABL.ST :
* SAID ON THURSDAY CO ANNOUNCED OUTCOME OF COMPLETED RIGHTS
ISSUE
* RIGHTS ISSUE WAS SUBSCRIBED TO A TOTAL OF ABOUT 90%,
INCLUDING
SUBSCRIPTION AND GUARANTEE COMMITMENTS
* STAYBLE WILL RECEIVE ABOUT SEK 31.7 MLN BEFORE ISSUE COSTS
Source text for Eikon: urn:newsml:reuters.com:*:nWkr74QqcS
Further company coverage: STABL.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Stayble Therapeutics AB
See all newsBrief: Stayble Therapeutics Delisted From Nasdaq First North Growth Market
Brief: Stayble Therapeutics To Apply For Bankruptcy
Brief: Stayble Therapeutics Q1 EBIT Loss Narrows To SEK 6.9 Mln
Brief: Stayble Therapeutics Enters Into LoI On Potential Strategic Collaboration, Financing
Brief: Stayble Therapeutics Q4 Oper Loss To SEK 1.5 Mln